Abbott Laboratories (ABT): Price and Financial Metrics

ABT POWR Grades

• Sentiment is the dimension where ABT ranks best; there it ranks ahead of 98.91% of US stocks.
• The strongest trend for ABT is in Quality, which has been heading up over the past 163 days.
• ABT ranks lowest in Momentum; there it ranks in the 19th percentile.

ABT Stock Summary

• ABT has a higher market value than 99.05% of US stocks; more precisely, its current market capitalization is $220,523,067,904.
• Abbott Laboratories's stock had its IPO on January 1, 1986, making it an older stock than 92.74% of US equities in our set.
• Over the past twelve months, ABT has reported earnings growth of 99.68%, putting it ahead of 80.01% of US stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Abbott Laboratories are TMO, NKE, CMCSA, ABBV, and NFLX.
• ABT's SEC filings can be seen here. And to visit Abbott Laboratories's official web site, go to www.abbott.com.

ABT Valuation Summary

• ABT's price/earnings ratio is 35.1; this is 3.84% lower than that of the median Healthcare stock.
• Over the past 243 months, ABT's price/sales ratio has gone up 0.3.
• Over the past 243 months, ABT's price/earnings ratio has gone down 10.1.

Below are key valuation metrics over time for ABT.

ABT Growth Metrics

Its year over year cash and equivalents growth rate is now at 138.5%.
• The 3 year net cashflow from operations growth rate now stands at 105.64%.
• The 4 year cash and equivalents growth rate now stands at 1.29%.

Over the past 49 months, ABT's revenue has gone up $17,174,000,000.

The table below shows ABT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-09-30	42,308	11,264	7,244
2021-06-30	40,233	10,629	6,376
2021-03-31	37,338	9,823	5,724
2020-12-31	34,608	7,901	4,495
2020-09-30	32,221	6,519	3,382
2020-06-30	31,444	6,401	3,110

ABT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ABT has a Quality Grade of B, ranking ahead of 77.76% of graded US stocks.
• ABT's asset turnover comes in at 0.559 -- ranking 70th of 680 Pharmaceutical Products stocks.
• DVAX, RARE, and CORT are the stocks whose asset turnover ratios are most correlated with ABT.

The table below shows ABT's key quality metrics over time.